The occurrence of non-anatomical therapeutic chemical-international nonproprietary name molecules in suspected illegal or illegally traded health products in Europe: A retrospective and prospective study.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Deconinck, EricVanhee, Celine
Keizers, Peter
Guinot, Pauline
Mihailova, Albena
Syversen, Per Vidar
Li-Ship, Graziella
Young, Steven
Blazewicz, Agata
Poplawska, Magdalena
Al-Sayed, Josephine Loasby
Stengelshøj Olsen, Lone
El-Atma, Oliver
Leist, Roman
Jönsson, Karl-Henrik
Afxentiou, Maria
Barrios, M Mendoza
Diaz, I Dorronsoro
Zemser, Marina
Kozokin, Alla
Hackl, Andreas
Portela, Maria-Jao
Beerbaum, Nico
Bertrand, Marie
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
The occurrence of non-anatomical therapeutic chemical-international nonproprietary name molecules in suspected illegal or illegally traded health products in Europe: A retrospective and prospective study.Published in
Drug Test Anal 2021; advance online publication (ahead of print)DOI
10.1002/dta.3001PMID
33453144ae974a485f413a2113503eed53cd6c53
10.1002/dta.3001
Scopus Count
Collections
Related articles
- Fighting trafficking of falsified and substandard medicinal products in Russia.
- Authors: Fayzrakhmanov NF
- Issue date: 2015
- [European Network of Official Medicines Control Laboratories : International OMCL Working Group Combating Counterfeit and other Illegal Medicines].
- Authors: Wanko R, Unkelbach U
- Issue date: 2017 Nov
- [The role of German official medicines control laboratories in combating counterfeit medicines].
- Authors: Wiegard A, Heuermann M
- Issue date: 2017 Nov
- Quality Control of Immunological Veterinary Medicinal Products in Europe.
- Authors: Pasik K, Łysiak E
- Issue date: 2019 Dec
- Analysis of illegal peptide biopharmaceuticals frequently encountered by controlling agencies.
- Authors: Vanhee C, Janvier S, Desmedt B, Moens G, Deconinck E, De Beer JO, Courselle P
- Issue date: 2015 Sep 1